Insulin glargine (HOE901) - First responsibilities: understanding the data and ensuring safety

被引：11
|
作者：
Buse, J [1 ]
机构：
[1] Univ N Carolina, Diabet Care Ctr, Durham, NC 27713 USA
来源：
DIABETES CARE | 2000年 / 23卷 / 05期
关键词：
D O I：
10.2337/diacare.23.5.576
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：576 / 578
页数：3
相关论文
共 41 条
  • [1] Time-action profile of insulin glargine (HOE901) in Japanese volunteers
    Rave, K
    Heise, T
    Heinemann, L
    DIABETES, 2000, 49 : A363 - A363
  • [2] Comparison of insulin Glargine (HOE901) vs NPH insulin during 1 year of insulin combination therapy in type 2 diabetes
    Yki-Jarvinen, H
    Dressler, A
    Zieman, M
    DIABETES, 2000, 49 : A130 - A131
  • [3] Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo
    Heinemann, L
    Linkeschova, R
    Rave, K
    Hompesch, B
    Sedlak, M
    Heise, T
    DIABETES CARE, 2000, 23 (05) : 644 - 649
  • [4] Insulin glargine. Glargine, HOE 71GT15, HOE 71GT80, HOE 901.
    不详
    Drugs in R & D, 1999, 2 (2) : 107 - 109
  • [5] Time-action profile of the long-acting insulin analogue HOE901
    Linkeschowa, R
    Heise, T
    Rave, K
    Hompesch, B
    Sedlack, M
    Heinemann, L
    DIABETES, 1999, 48 : A97 - A97
  • [6] Efficacy of the new long acting insulin analog (HOE901) on fasting glucose values in IDDM
    Garg, S
    Gerard, L
    Pennington, M
    Mecca, T
    Taylor, L
    Chase, P
    Jennings, K
    DIABETES, 1998, 47 : A359 - A359
  • [7] Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patients
    Pfeiffer, C
    Winkler, F
    Luger, A
    Pieber, T
    Saudek, F
    Skrha, J
    Hermansen, K
    Lervang, HH
    Nistrup-Holmegaard, S
    Bergkulla, S
    Lembcke, HJ
    Schulze, J
    Petersen, KG
    Haslbeck, M
    Jonker, JJC
    Vaaler, S
    Rolstad, OJ
    Distiller, LA
    Robertson, LI
    Omar, MAK
    Wing, J
    Arner, P
    Arnqvist, H
    Lager, I
    Lennerhagen, P
    Borthwick, LJ
    Hattersley, A
    Owens, DR
    Matthews, DR
    Nattrass, M
    DIABETIC MEDICINE, 2003, 20 (07) : 545 - 551
  • [8] HUMAN INSULIN ANALOG HOE901 - CHARACTERISTICS OF RECEPTOR-BINDING AND TYROSINE KINASE ACTIVATION
    BERTI, L
    SEFFER, E
    SEIPKE, G
    KRODER, G
    HARING, HU
    DIABETES, 1995, 44 : A243 - A243
  • [9] HOE 901 (insulin glargine) improves satisfaction with intensified insulin treatment for type 1 diabetes.
    Witthaus, E
    Bradley, C
    Stewart, J
    DIABETOLOGIA, 1999, 42 : A235 - A235
  • [10] Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes
    Moriyama, H
    Nagata, M
    Fujihira, K
    Yamada, K
    Chowdhury, SA
    Chakrabarty, S
    Jin, ZZ
    Yasuda, H
    Ueda, H
    Yokono, K
    DIABETES CARE, 2001, 24 (02) : 411 - 412
12345